Simplex Trading
MRNA icon

Simplex Trading’s Moderna MRNA Stock Holding History

Simplex Trading’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.8M Sell
154,558
-65,015
-30% -$3.36M 0.01% 710
2026
Q1 		$11.2M Buy
219,573
+129,897
+145% +$6.06M 0.01% 655
2025
Q4 		$2.64M Sell
89,676
-245,712
-73% -$6.68M ﹤0.01% 1756
2025
Q3 		$8.66M Sell
335,388
-46,399
-12% -$1.29M ﹤0.01% 1058
2025
Q2 		$10.5M Buy
381,787
+190,557
+100% +$5.02M 0.01% 858
2025
Q1 		$5.42M Buy
191,230
+87,027
+84% +$3.09M ﹤0.01% 1257
2024
Q4 		$4.33M Buy
+104,203
New +$4.98M ﹤0.01% 1588
2024
Q2 		– Sell
-24,885
Closed -$3.15M – 9432
2024
Q1 		$2.65M Buy
+24,885
New +$2.51M ﹤0.01% 2131
2023
Q4 		– Sell
-120,949
Closed -$10.2M – 9438
2023
Q3 		$12.5M Buy
120,949
+106,352
+729% +$11.9M 0.01% 821
2023
Q2 		$1.77M Buy
+14,597
New +$1.95M ﹤0.01% 2065
2022
Q4 		– Sell
-42,209
Closed -$6.9M – 9938
2022
Q3 		$4.99M Sell
42,209
-38,828
-48% -$5.89M 0.01% 1212
2022
Q2 		$11.6M Buy
81,037
+7,033
+10% +$1.01M 0.01% 742
2022
Q1 		$12.7M Buy
74,004
+72,754
+5,820% +$12.2M 0.01% 717
2021
Q4 		$317K Sell
1,250
-25,831
-95% -$7.55M ﹤0.01% 4479
2021
Q3 		$6.37M Sell
27,081
-3,694
-12% -$1.36M 0.01% 1009
2021
Q2 		$7.23M Buy
+30,775
New +$5.5M 0.01% 902
2021
Q1 		– Sell
-56,919
Closed -$8.25M – 9570
2020
Q4 		$5.95M Sell
56,919
-96,909
-63% -$9.8M 0.01% 862
2020
Q3 		$0 Buy
153,828
+40,423
+36% +$2.82M ﹤0.01% 8206
2020
Q2 		$7.28M Sell
113,405
-5,413
-5% -$296K 0.01% 654
2020
Q1 		$3.56M Buy
118,818
+86,366
+266% +$1.99M 0.01% 889
2019
Q4 		$634K Sell
32,452
-25,499
-44% -$452K ﹤0.01% 2514
2019
Q3 		$922K Buy
57,951
+10,813
+23% +$160K ﹤0.01% 2008
2019
Q2 		$690K Buy
47,138
+32,760
+228% +$704K ﹤0.01% 2273
2019
Q1 		$292K Buy
14,378
+13,278
+1,207% +$246K ﹤0.01% 3220
2018
Q4 		$16K Buy
+1,100
New +$18.1K ﹤0.01% 5521

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Simplex Trading's MRNA Position: Q2 2026 in Review

Simplex Trading reduced its Moderna (MRNA) stake by 30% in Q2 2026, selling an estimated $3.36M and leaving 154,558 shares worth $10.8M. The position accounts for 0.01% of the portfolio, ranked #710.

Simplex Trading first reported a position in MRNA in Q4 2018 and has held it in 25 quarters since. The position peaked at $12.7M in Q1 2022. 783 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Simplex Trading held 154,558 shares of Moderna worth $10.8M as of Q2 2026.
  • Simplex Trading sold 65,015 Moderna shares in Q2 2026, an estimated $3.36M.
  • Moderna made up 0.01% of Simplex Trading's portfolio in Q2 2026, its #710 holding.
  • Simplex Trading first reported a position in Moderna in Q4 2018 and has held it in 25 quarters since.
  • Simplex Trading's Moderna position peaked at $12.7M in Q1 2022.
  • 783 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.